About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT05660499

Impact of the Development of Pediatric Palliative Care

Despite medical advances, cancer remains the leading cause of death by disease in children. Brain tumors are the second most common cause of cancer in children after leukemia, representing 25% of ped...

Lead sponsor: University Hospital, Strasbourg, France•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Nadine COJEAN, MD

CONTACT

33 6 21 11 16 01 nadine.cojean@chru-strasbourg.fr

Sponsors

Lead Sponsor

University Hospital, Strasbourg, France

The main objective of the study is to compare the occurrence and management of end-of-life symptoms in children who died of a primary brain tumor over 2 periods, in 2009 - 2010 and in 2019 - 2020, followed in the Pediatric Oncology departments of Strasbourg, Besançon, Dijon, Nancy and Reims.

Age

1 - 17 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patient less than 17 years of age
•Suffering from a primary brain tumor
•Died during the period 2009-2010 or during the period 2019-2020
•Follow-up in one of the Pediatric Oncology departments participating in the study (Strasbourg, Besançon, Dijon, Nancy and Reims)
•Absence of refusal expressed in the medical file by the parents or the holder(s) of parental authority concerning the reuse of the child's personal data for research purposes.

Exclusion Criteria

•Refusal expressed in the medical file by the parents or the holder(s) of parental authority concerning the reuse of the child's personal data for research purposes
•Patient with a brain tumor secondary to another cancer

Related studies

Assessment of Eloquent Function in Brain Tumor Patients

NCT01535430 · Primary Brain Tumor, Metastatic Brain Tumor

Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors

NCT06831461 · Primary Brain Tumors, Diffuse Glioma, and more

Active Not RecruitingEARLY Phase 1

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

NCT05634707 · Primary Brain Tumor, Brain Tumor, Recurrent

Not Yet RecruitingPhase 2

Pharmacoscopy for Patients With Refractory Primary Brain Tumors

NCT06804655 · Brain (Nervous System) Cancers, Glioblastoma, and more

Survivorship Study of Cancer Patients Who Received Cranial Radiation Therapy

NCT04567251 · Brain Metastases, Adult, Primary Brain Tumor, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 14, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment40

Start dateFeb 2021

Last updatedDec 14, 2023

Condition

Primary Brain Tumor

Locations shown

Service de soins Palliatifs - CHU de Strasbourg - France

Strasbourg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 14, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions